This inventor holds 1 USPTO granted patent. Top assignee: Lg Chem-Investment Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Young-Leem Oh: Innovator in Isoxazoline Derivatives
Introduction
Young-Leem Oh is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isoxazoline derivatives. His research focuses on developing compounds that can inhibit the activity of caspases, which are crucial in various cellular processes.
Latest Patents
Young-Leem Oh holds a patent for an isoxazoline derivative and a process for its preparation. The invention provides a compound that can be used in pharmaceutical compositions aimed at preventing inflammation and apoptosis. This is particularly relevant for treating diseases associated with abnormal cell death, such as dementia, cerebral stroke, AIDS, diabetes, gastric ulcers, hepatic injury from hepatitis, sepsis, and organ transplantation rejection reactions.
Career Highlights
Young-Leem Oh is currently associated with LG Chem Investment Ltd., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact various medical fields significantly.
Collaborations
Some of his coworkers include Eunice Eun-Kyeong Kim and Mi-Jeong Park, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Young-Leem Oh's contributions to the field of pharmaceuticals through his innovative isoxazoline derivatives highlight the importance of research in developing new treatments for critical health issues. His work exemplifies the intersection of science and innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile